Our clients take advantage of OCT specialized therapeutic experience in endocrinology clinical trials because OCT can offer quick patients’ recruitment and high quality data. What is more, OCT clinical operations team are very well trained in this indication and they are ready to share their experience in endocrinology trials with our clients.

In the past five years, OCT has conducted and supported several protocols in endocrinologic indication involving countries in Central and Eastern Europe such as Russia, Ukraine, Belarus, Latvia, Lithuania, Estonia and Bulgaria.

 We have successfully managed national and multinational clinical studies for a broad range of endocrine indications including:

  • Diabetes mellitus
  • Osteoporosis, post menopausal
  • Type 2 diabetes
  • Hypothyriosis
  • Autoimmune thyroiditis
  • Diabetic ulcers
  • Infertility
  • Sexual dysfunction

We have experience in early and late stages of drug development.

We can organize and run excellent investigator meetings, secure all necessary regulatory approvals, engage highly qualified investigators, set up the database, depot and lab arrangements quickly and efficiently.

Russia, Central and Eastern Europe provide good clinical research environment for endocrinology trials. Highly successful patient recruitment rates are a result of several factors including region size, treatment-naïve population, centralized healthcare system.
There is a wide spectrum of diseases undergoing clinical research in CEE countries. The most popular areas in Russia and CEE include oncology, cardiology and endocrinology. At the moment  there is a growing incidence of diabetes in Russia. Russia is reported to have one of the highest incidence of diabetes in the world. That is why there is a corresponding increase in the number of clinical studies involving diabetes patients in our region.

Please contact us if you want to know more about OCT experience in endocrinology.